Northwestern University researchers use gold standard liquid-biopsy technology to deepen understanding of metastatic breast cancer
Northwestern University researchers use gold standard liquid-biopsy technology to deepen understanding of metastatic breast cancer
Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells
Automated volume reduction instrument increases precision and accuracy in rare cell workflows
Topics: Liquid biopsy, Precision Medicine, rare cells, volume reduction, VRNxT
09/23/2019
World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer
Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells
Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis
Topics: CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer
03/27/2019
Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker
Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma
03/12/2019
Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression
Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs
Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients
Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer
Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy
Topics: CTCs, DEPArray NxT, NGS, CELLSEARCH, Liquid biopsy, Precision Medicine, low-pass, copy number alteration
Second World Summit on Cancer Heterogeneity and Precision Medicine Meets in Washington
Topics: FFPE, CTCs, Liquid biopsy, International experts, Menarini International Foundation, Precision Medicine, Cancer Heterogeneity, International conference